Clinical Study to Evaluate the Effects and Safety of Green Tea Extract on Blood Glucose Regulation

Launched by AMOREPACIFIC CORPORATION · Sep 9, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how green tea extract might help lower blood sugar levels in adults. Researchers want to see if taking green tea extract can be beneficial for people whose fasting blood sugar levels are slightly elevated. They are currently recruiting participants aged 19 to 64 years who have a body mass index (BMI) between 18.5 and 29.9 and whose fasting blood sugar is between 100 and 139 mg/dL. However, people with certain health conditions, such as diabetes or other serious medical issues, will not be eligible to participate.

If you qualify and decide to join the study, you will be asked to take green tea extract and monitor your blood sugar levels. This trial aims to understand both the effects and safety of green tea extracts on blood sugar regulation. Participating in this study could help researchers learn more about how natural products like green tea might support blood sugar management, which could be beneficial for many people in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Males and females aged between 19 to 64 years
• • BMI between 18.5 and 29.9kg/m²
• • fasting blood glucose between 100 and 139 mg/dL (Note: if some subjects with blood glucose range of 126 - 139 mg/dL, those who are taking or requre medication must be excluded to meet ethical standards.)
• • subjects who voluntarily decide to participate in this study and sign the informed consent form.
• Exclusion Criteria:
• • Individuals taking to obesity, dyslipidemia, or uncontrolled hypertension at the screening
• • Individuals diagnosed with diabetes and who have taken medications related to blood glucose
• • Individuals congenital enzyme deficiencies related to sugar metabolism.
• • with hypersensitivity to the test food or ingredients(e.g., green tea, caffeine).
• • Individuals ongoing treatment diseases significantly related glucose metabolism.
• • Individuals with a history of surgery significantly related to glucose metabolism within the last 6 months
• • diagnosed with gastrointestinal diseases, cardiovascular diseases, uncontrolled chronic medical conditions, thyroid disorders, or active malignant tumors requiring medication
• • Individuals with liver function impairment or acute or chronic hepatitis or liver cirrhosis
• • Individuals with renal disorder
• • Individuals with a weight change of 5 kg or more within the last 3 months.